SCIENTIFIC POSTER
Automation for organoid assays: An integrated system with high-content imaging
Automate organoid development—from cell culturing to high-content imaging—for high-throughout compound screening assays
Three-dimensional (3D) cell models are being successfully used in drug discovery and disease modeling to study complex biological effects and tissue architecture. However, the complexity of 3D models remains a hurdle for their wider adoption.
In this poster, we describe an automated method to successfully test the effects of different compounds, evaluate toxicity, and develop disease modeling using 3D cell models.
Learn more about the systems behind the methods:
More great resources
Application Note
Automation and high content imaging of 3D triple-negative breast cancer patient-derived…
Triple negative breast cancer is a clinically aggressive tumor subtype, with high rates of metastasis, recurrence, and drug…
Application Note
Automation of an organ-on-a-chip assay: automated culture, imaging, and analysis of…
3D cellular models are increasingly popular in many areas of research because they recapitulate the cellular 3D…
Application Note
Automated Monitoring of Development and Activity Analysis of iPSC-derived 3D Cerebral…
The human brain is highly complex which makes it challenging to study both in vitro and in-model organisms. Cultured neurons…